Iovance Biotherapeutics Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Corporate Update

Go back to Iovance Biotherapeutics Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Corporate Update
(NASDAQ: IOVA) Delayed: 10.22 -0.03 (0.29%)
Previous Close $10.25    52 Week High
Open $10.43    52 Week Low
Day High $10.64    P/E N/A 
Day Low $10.17    EPS
Volume 6,711,035